# Taste Properties of Atazanavir and Cobicistat

> **NCT02307656** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 6 (actual)

## Conditions studied

- HIV in Adults

## Interventions

- **DRUG:** Atazanavir
- **DRUG:** Cobicistat
- **DRUG:** Active Pharmaceutical Ingredient

## Key facts

- **NCT ID:** NCT02307656
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-12
- **Primary completion:** 2021-09-09
- **Final completion:** 2021-09-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307656, "Taste Properties of Atazanavir and Cobicistat". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02307656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*